Skip to main content
Premium Trial:

Request an Annual Quote

Affy's Purchase of True Materials Topped Most-Read GenomeWeb Daily News Articles Last Week

NEW YORK (GenomeWeb News) - What are GenomeWeb Daily News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Aug. 1.
 
1) Affymetrix Confirms Purchase of True Materials (from July 28)
 
2) Abbott Has No Intentions to Sell Dx Businesses, Officials Say (from July 30)
 
3) GE Streamlines Structure; Healthcare No Longer Standalone Unit (from July 28)
 
4) Seegene, Shimadzu Ink Molecular Dx Pact (from July 28)
 
5) Commentary Calls for Translational Studies to Advance Personal Genomics (from July 29)
 
 
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.